-
- Verwendungszweck
- PPAR alpha agonist
- Reinheit
- 98.5 % (HPLC), NMR (Conforms), MS (Conforms)
- Chemical Name
- 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid, Pirinixic acid, 2-[4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl]sulfanylacetic acid, WY-14,643, WY14643, WY 14643, Wyeth 14,643
- Formel
- C14H14ClN3O2S
- Löslichkeit
- Soluble in DMSO (40 mg/ml)
-
-
- Kommentare
-
Source: Synthetic. Appearance: Off white powder
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Handhabung
- Classification: D2B Toxic Material Causing Other Toxic Effects Moderate skin irritant - Moderate respiratory irritant, Moderate eye irritant Hazard statement(s): H302 Harmful if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H350 May cause cancer. Precautionary statement(s): P201 Obtain special instructions before use. P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
- Lagerung
- -20 °C
-
- Molekulargewicht
- 323.8
- CAS-Nummer
- 50892-23-4
-
Sie sind hier:
